Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Allendorf

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
NPJ Precision Oncology|March 3, 2025
Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomesXiaofei Zhang, Ruoxin Lan, Yongjun Liu, et al.
Cancer Chemotherapy and Pharmacology|February 2, 2013
Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experienceRobert L Fine, Anthony P Gulati, Benjamin A Krantz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
Soluble Ig-like transcript 3 inhibits tumor allograft rejection in humanized SCID mice and T cell responses in cancer patientsNicole Suciu-Foca, Nikki Feirt, Qing-Yin Zhang, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
NPJ Precision Oncology|March 3, 2025
Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomesXiaofei Zhang, Ruoxin Lan, Yongjun Liu, et al.
Cancer Chemotherapy and Pharmacology|February 2, 2013
Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experienceRobert L Fine, Anthony P Gulati, Benjamin A Krantz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
Soluble Ig-like transcript 3 inhibits tumor allograft rejection in humanized SCID mice and T cell responses in cancer patientsNicole Suciu-Foca, Nikki Feirt, Qing-Yin Zhang, et al.
Pageof 3